BioBridgeXAll companies

Replimune Group, Inc.

Biotechnology company · Woburn, Massachusetts, United States · Nasdaq: REPL

Replimune Group, Inc. is a biotechnology company headquartered in Woburn, Massachusetts, United States. Its shares trade on Nasdaq under the ticker REPL. The US FDA lists 1 drug manufacturing or testing site registered to the company.

Profile compiled from public records. Is this your company? Request a correction or update

Replimune Group at a glance

Typebiotechnology company
HeadquartersWoburn, Massachusetts, United States
Stock listingNasdaq: REPL
SEC industryBiological Products, (No Diagnostic Substances)
FDA-registered sites1, plus sites in 1 other country
SEC CIK1737953

What does Replimune Group do?

Operations at its FDA-registered drug sites

AnalysisAPI manufacturingLabelingManufacturingPacking

Where is Replimune Group located?

Headquarters: Woburn, Massachusetts, United States

  • Framingham, MassachusettsReplimune, Inc. · FDA drug site

International sites registered with the FDA

Abingdon, United Kingdom

Frequently asked questions about Replimune Group

Where is Replimune Group headquartered?

Replimune Group, Inc. is headquartered in Woburn, Massachusetts, United States.

What does Replimune Group do?

Replimune Group, Inc. is a biotechnology company. Its FDA-registered drug sites are registered for analysis, API manufacturing, labeling and manufacturing. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Replimune Group a public company?

Yes. Replimune Group, Inc. trades on Nasdaq under the ticker REPL.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Last updated 2026-09-23. Data licences